Summit Corporation PLC : Notice of AGM
Summit Corporation plc
('Summit' or 'the Company')
NOTICE OF ANNUAL GENERAL MEETING
Oxford, UK, 01 June 2012, Summit (AIM: SUMM), a UK drug discovery Company announces that its Annual Report and Accounts for the year ended 31 January 2012 ('Annual Report') together with the Notice of Annual General Meeting ('AGM') have been posted to shareholders. Copies of the Annual Report will shortly be available on the Company's website, www.summitplc.com.
The AGM will be held at 10:00am on Wednesday 18 July 2012 at Milton Park Innovation Centre, 99 Milton Park, Abingdon, Oxfordshire, OX14 4RY.
- END -
For more information, please contact:
Glyn Edwards / Richard Pye
| Tel: +44 (0)1235 443 939 |
|Singer Capital Markets |
(Nominated Adviser and Joint broker)
Shaun Dobson / Claes Spång
Tel: +44 (0)203 205 7500
Claire Louise Noyce / Deepak Reddy
Tel: +44 (0)207 947 4350
(Financial public relations)
Tel: +44 (0)7879 458 364
Notes to Editors
Summit is an Oxford, UK based drug discovery Company with an innovative Seglin(TM) technology platform for the discovery of new medicines and a portfolio of drug programme assets. Summit's programme portfolio consists of a number of drug programmes targeting high-value areas of unmet medical need including Duchenne Muscular Dystrophy and C. difficile infection. Summit is listed on the AIM market of the London Stock Exchange and trades under the ticker symbol SUMM. Further information is available at www.summitplc.com.
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Summit Corporation PLC via Thomson Reuters ONE